HNB
ADMA icon

Huntington National Bank’s ADMA Biologics ADMA Stock Holding History

Huntington National Bank’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14
Closed -$205 – 4111
2025
Q3 		$205 Sell
14
-169
-92% -$2.9K ﹤0.01% 2536
2025
Q2 		$3.33K Buy
183
+56
+44% +$1.14K ﹤0.01% 2103
2025
Q1 		$2.52K Sell
127
-19
-13% -$329 ﹤0.01% 2170
2024
Q4 		$2.5K Sell
146
-106
-42% -$1.99K ﹤0.01% 2196
2024
Q3 		$5.04K Buy
252
+12
+5% +$187 ﹤0.01% 1994
2024
Q2 		$2.68K Buy
+240
New +$2.01K ﹤0.01% 2084

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Huntington National Bank's ADMA Position: Q4 2025 in Review

Huntington National Bank sold out of ADMA Biologics (ADMA) in Q4 2025, closing a stake of 14 shares — an estimated $205 sold.

Huntington National Bank first reported a position in ADMA in Q2 2024 and held it in 6 quarters. The position peaked at $5.04K in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q4 2025.

  • Huntington National Bank reported no remaining ADMA Biologics position as of Q4 2025 after selling out during the quarter.
  • Huntington National Bank sold 14 ADMA Biologics shares in Q4 2025, an estimated $205.
  • Huntington National Bank first reported a position in ADMA Biologics in Q2 2024 and held it in 6 quarters.
  • Huntington National Bank's ADMA Biologics position peaked at $5.04K in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2025.

Based on Huntington National Bank's 13F filing for Q4 2025, filed 9 Feb 2026.